StockClub

CVKD

CVKDCadrenal Therapeutics, Inc. Common Stock$ --
Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-3M USD
YoY +36.0%
Net Income
-2M USD
YoY +35.1%
EPS
-1.04$
YoY +50.2%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-2.5M
FY2024 Q2$-4.1M
$-4.1M
Q2
FY2024 Q3$-6.5M
$-6.5M
Q3
FY2024 Q4$-10.7M
$-10.7M
Q4
FY2025 Q1$-3.8M
$-3.8M
Q1
FY2025 Q2$-7.5M
$-7.5M
Q2
FY2025 Q3$-10.2M
$-10.2M
Q3
FY2025 Q4$-13.2M
$-13.2M
Q4
FY2026 Q1$-2.5M
$-2.5M
Q1
Actual
+$1.3M (+35.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024IN-LINE
Actual:$0
Est:$0
FY2024IN-LINE
$0
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates